Effects of Exemestane on Bone Strength (MAP3BSS)
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Sponsor: Canadian Breast Cancer Research Alliance
A observational or N/A phase clinical study on Breast Cancer and Osteoporosis, this trial is completed. The trial is conducted by Canadian Breast Cancer Research Alliance and has accumulated 8 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Apr 2024 [monthly]
Unknown Status
-
Jul 2019 — Jan 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Breast Cancer Research Alliance
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .